The Lung Cancer Consortium Singapore (LCCS) was established in 2001, with the aim to bring together the clinical and research community in order to advance the diagnosis and management of thoracic cancers.
.
The Lung Cancer Education and Advocacy for Patients (LEAP) aims to support lung cancer patients in Singapore through providing educational resources on the disease, and creating awareness through our patient advocacy group.
Early detection of lung cancer can save lives! We welcome at-risk individuals to come forward for low-dose CT screening through our clinical research study, SOLSTICE. Click here to find out if you are eligible.
.
The Lung Cancer Consortium Singapore (LCCS) was established in 2001, with the aim to bring together the clinical and research community in order to advance the diagnosis and management of thoracic cancers.
The Lung Cancer Education and Advocacy for Patients (LEAP) aims to support lung cancer patients in Singapore through providing educational resources on the disease, and creating awareness through our patient advocacy group.
Early detection of lung cancer can save lives! We welcome at-risk individuals to come forward for low-dose CT screening through our clinical research study, SOLSTICE. Click here to find out if you are eligible.
.
UPCOMING EVENTS
November is Lung Cancer Awareness Month (LCAM)! All who are on this journey to overcome lung cancer, have come together to share their experience and stories to raise awareness. We strive to improve public knowledge about lung cancer and empower every individual in this fight against lung cancer. Let’s answer the call to action and do our part to beat lung cancer!
SOLSTICE
Singapore Lung cancer Screening Through Integrating CT with other biomarkers (SOLSTICE) is the first local lung cancer screening study. It is helmed by a multidisciplinary clinical team comprising of medical oncologists, pulmonologists, cardiothoracic surgeons and radiologists from SingHealth. This study is funded under the National Medical Research Council’s (NRMC) Open Fund – Large Collaborative Grant (OF-LCG) and falls within the theme of population health outcomes under a Lung Cancer programme.
PATIENT STORIES
https://lccs.com.sg/wp-content/uploads/2026/03/Mr-Kong-LEAP.png 310 351 wan@cleveraa.com https://lccs.com.sg/wp-content/uploads/2020/10/LCCS_logo-1.png wan@cleveraa.com2026-03-11 18:12:042026-03-20 13:14:04LEAP | Diagnosed with Stage 4 cancer, Mr Kong’s priority was his wife and children
https://lccs.com.sg/wp-content/uploads/2024/11/LCCS-Video-Thumbnail.png 312 353 wan@cleveraa.com https://lccs.com.sg/wp-content/uploads/2020/10/LCCS_logo-1.png wan@cleveraa.com2024-11-01 16:43:082024-11-07 02:45:22Finding Strength in Community – Mdm Peggy Lim’s Story
https://lccs.com.sg/wp-content/uploads/2024/11/Peggy.jpg 1000 1000 wan@cleveraa.com https://lccs.com.sg/wp-content/uploads/2020/10/LCCS_logo-1.png wan@cleveraa.com2024-11-01 10:56:002024-11-07 02:45:02Finding Strength in Community – Mdm Peggy Lim Shares Her StorySUPPORT
Let’s answer the call to action and do our part to overcome lung cancer. Your gift will go a long way in allowing us to better support our lung cancer patients on their recovery journey through patient education and patient support initiatives.
If you would like to join us in the fight against lung cancer, do reach out to us at leap@nccs.com.sg
INDUSTRIAL PARTNERS
NETWORK
“I Can. We Will” is a campaign brought to you by MSD which aims to educate and raise awareness for lung cancer patients, caregivers and the general public about lung cancer and potential treatment options
Singapore Cancer Society’s Mission is to minimise cancer and maximise lives through effective programmes and be Singapore’s leading charity in the fight for a cancer-free community.
The Asian Thoracic Oncology Research Group (ATORG) was formed with the vision to be the central coordinating platform for multi-centre clinical trials and translational research for thoracic malignancies in the Asia-Pacific region
The Singapore Society of Oncology (SSO), is a professional medical organisation for all Singapore healthcare professionals who treat and manage cancer patients. The aim of the SSO is to provide an active platform to promote the practice of oncology through education, research, collaborations and partnerships with allied local, regional and international organisations.
FIND US
Lung Cancer Consortium Singapore
C/O National Cancer Centre Singapore
30 Hospital Boulevard, Singapore 168583
CONTACT US
Email: leap@nccs.com.sg
FOLLOW US ON SOCIAL MEDIA
 |  |  |
Lung Cancer Education and Advocacy for Patients
The Lung Cancer Education and Advocacy for Patients (LEAP) aims to support lung cancer patients in Singapore through providing educational resources on the disease, and creating awareness through our patient advocacy group.
Sometimes, a change of plans can lead to meaningful moments
Our lung cancer support group had originally planned for a morning walk at Fort Canning last Saturday, but with the hazy weather keeping us indoors, we swapped our walking shoes for coffee and conversation instead. ☕️
What followed was a morning of genuine connection, as patients shared their experiences, supported one another and connected with others on similar journeys. Patient advocates and healthcare professionals also joined in, offering their lived experiences, perspectives and insights.
While we may not have gotten to take the walk we planned, we were reminded that sometimes, simply having the space to sit together, listen, share and connect can be just as meaningful.
Thank you to everyone who joined us and contributed so openly to the morning! We look forward to many more opportunities to walk, talk and connect together. 🌿
#LungCancerSupport #PatientSupport #PatientCommunity #CancerSupport #NCCS ... See MoreSee Less
0 CommentsComment on Facebook
Our patient advocate Ms Angelina Low recently spoke at a secondary school assembly, sharing important lessons on lung cancer awareness, prevention, early detection, and the importance of living well. Through personal stories, students learned that cancer is not just about treatment, but also about hope, resilience, and supporting one another.
By raising awareness early, we can help build confidence, dispel myths, and inspire future generations to make informed health choices.
#lungcancerawareness #patientadvocacy #HealthEducation #NCCS #HopeAndResilience #EarlyDetection ... See MoreSee Less
0 CommentsComment on Facebook
What matters most to you in lung cancer treatment?
An international EORTC (European Organisation for Research and Treatment of Cancer) survey is inviting patients with any type or stage of lung cancer to share their experiences and priorities in treatment. Researchers want to understand what patients truly value to ensure future research reflects what patients really want and need, especially for stage 3 EGFR-mutated lung cancer.
Share your thoughts and take part in this survey.
English: form.gov.sg/693a7be33f7e3c524fa599dd
Chinese: form.gov.sg/696846fa64be73e344ca18d9
🌍 Share your voice, Shape the research. Improve the future of lung cancer care.
#patientexperience
#eGFR
#lungcancerresearch
#eortc
#PatientCentredCare ... See MoreSee Less
0 CommentsComment on Facebook
Join us for our upcoming September event!
Lung Cancer Will Not Keep Me Down
Fort Canning walk
📆05 Sep 2026 (Sat)
🕣8.30am
Meeting point: Dhoby Ghaut MRT Exit B
Whatsapp Cheryl 8548 8543 if interested. ... See MoreSee Less
0 CommentsComment on Facebook
... See MoreSee Less
This content isn't available right now
When this happens, it's usually because the owner only shared it with a small group of people, changed who can see it or it's been deleted.0 CommentsComment on Facebook
LEAP recently conducted an EGFR Lung Cancer Focus Group, bringing together patients to share their perspectives and experiences across different aspects of their treatment journey.
The session provided an opportunity to better understand patients’ views on treatment options, treatment-related challenges, living with treatment, and their information and support needs.
Insights gathered from the discussion will help LEAP identify areas that matter most to patients and inform the development of future patient education, resources and support initiatives that are relevant to the needs of the lung cancer community.
We thank the participants for contributing their time and perspectives to this discussion.
We also thank our industry partners AstraZeneca,
Daiichi Sankyo, Johnson & Johnson and Roche for their support in this patient focus group.
LEAP remains committed to strengthening patient education and support through continued engagement with the lung cancer community.
To learn more about LEAP and our programmes, follow LEAP Singapore or visit our website.
#LEAPSG #EGFR #PatientEngagement #PatientVoices #LungCancerSupport ... See MoreSee Less
1 CommentsComment on Facebook